Senescent astrocytes identified as key progression'>drivers of Alzheimer's progression is drawing significant interest across the industry.
Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with IBIMA-BIONAND Platform and CIBERNED, have made a pioneering breakthrough in the fight against this disease by identifying astrocytes as a promising cellular target for the development of future therapies.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →